 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Pancreatic Cancer
Alimta (pemetrexed sodium)
| Multi-targeted folate inhibitor |
Eli Lilly |
II |
| AMD-473 |
Platinum |
AnorMed |
II |
| Avastin (bevacizumab) |
Anti VEGF |
Genentech |
II |
| Avicine (CTP-37) |
Vaccine |
AviBioPharma Inc. SuperGen |
III |
| BBR 3464 |
Platinum compound |
Novuspharma |
II |
| CEP-701 |
FLT3 inhibitor |
Cephalon |
II |
| Eloxatin (oxaliplatin) |
Alkylating agent |
Sanofi-Synthelabo |
III |
| Erbitux (cetuximab) |
Anti-EGFR monoclonal antibody |
ImClone Systems and Bristol-Myers Squibb |
III |
| Exatecan |
Topoisomerase inhibitors |
AstraZeneca |
III |
| GBC-590 |
Galectin-3 inhibitor |
Glyco Genysis |
I |
| GCS-100 (citrus pectin) |
AKTI inhibitor |
Glyco Genesys |
II |
| GD0039 |
Hydrochloride salt of sawinsonine class |
Inflazyme |
II |
| GVAX |
Vaccine |
Cell Genesys |
II |
| Immu-101 (labetuzumab-y) |
Radiolabled MoAB |
Immunomedics |
I |
| Irofulven |
Hydroxymmethylacylufulvene |
MGI |
II |
| ISIS 2503 |
Antisense therapy |
ISIS Pharmaceuticals |
II |
| Oncophase |
Heat shock protein pepetide complex 96 |
Antigenics |
I |
| Panvac-VF |
Vaccine |
Therion Biologics |
III |
| Prothecan (Peg-camptothecin) |
Pegylated camptothecin |
Enzon |
II |
| Tarceva (erlotinib) |
EGF tyrosine kinase inhibitor |
Genentech, OSI Pharmaceuticals |
Approved 11-2-05 |
| Taxoprexin (docosahexaenoic acid-paclitaxel) |
Taxane |
Protarga |
III |
| Taxotere (docetaxel) |
Taxoid |
Aventis |
II |
| Thymitaq (nolatrexed) |
Thymidylate synthase inhibitor |
Eximias |
II |
| TNFerade |
Tumor necrosis factor alpha gene |
GenVec |
II |
| Troxatyl (troxacitabine) |
Dioxolane nucleoside analog |
MGI Shire US Inc. |
II |
| Virulizin |
Macrophage activator |
Lorus Therapeutics |
III |
| Xeloda (capecitabine) |
Fluoropyrimidine carbamate |
Roche |
III |
|
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
